Citations

"Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation model." Lancet Glob Health 9, no. 11 (2021): e1539-e1552.

"The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults." Lancet Healthy Longev 2, no. 6 (2021): e340-e351.

Marcus, M. E, J. Manne-Goehler, M. Theilmann, F. Farzadfar, S. S Moghaddam, M. Keykhaei, A. Hajebi, S. Tschida, J. M Lemp, K. K Aryal, M. Dunn, C. Houehanou, S. Bahendeka, P. Rohloff, R. Atun, T. W Bärnighausen, P. Geldsetzer, and Ramirez. "Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: A cross-sectional study of nationally representative, individual-level data." The Lancet Global Health 10, no. 3 (2022): e369-e379.

"Unmet need for hypercholesterolemia care in 35 low- and middle-income countries: A cross-sectional study of nationally representative surveys." PLoS Med 18, no. 10 (2021).

"Cardiovascular disease risk profile and management practices in 45 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level survey data." PLoS Med 18, no. 3 (2021).

"Diabetes Prevalence and Its Relationship With Education, Wealth, and BMI in 29 Low- and Middle-Income Countries." Diabetes Care 43, no. 4 (2020): 767-775.